Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the prior v3.6.2. This update reflects a new entry version for the ClinicalTrials.gov page rather than changes to the study details.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page revision identifier was updated from v3.6.0 to v3.6.2, indicating a new version of the page content. This update represents a minor administrative change rather than substantive changes to the study details.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded recruitment status note and new user guidance sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updated the label to 'Intervention/Treatment'. Removed the old 'Intervention / Treatment' label and updated the revision banner from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check40 days agoChange DetectedThe revision tag on the page changed from Revision: v3.5.4 to Revision: v3.5.5, indicating a version update of the page’s content or template. This appears to be a behind-the-scenes update rather than a substantive change to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now displays Revision: v3.5.4 instead of Revision: v3.5.3, indicating a backend/content-management update. No substantive content on the Study Details page appears to be altered.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s footer/update indicator changed from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a tooling or presentation version update rather than a change to the underlying study record.SummaryDifference0.1%

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.